Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
159 hedge funds and large institutions have $382M invested in Spectrum Pharmaceuticals Inc in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 79 increasing their positions, 26 reducing their positions, and 22 closing their positions.
204% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 26
53% more capital invested
Capital invested by funds: $250M → $382M (+$132M)
5% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 22
1% more funds holding
Funds holding: 158 → 159 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less call options, than puts
Call options by funds: $532K | Put options by funds: $606K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$28.8M |
| 2 |
BlackRock
New York
|
+$26.9M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
+$12.7M |
| 4 |
JP Morgan Chase
New York
|
+$2.37M |
| 5 |
Millennium Management
New York
|
+$1.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$4.03M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.37M |
| 3 |
D.E. Shaw & Co
New York
|
-$2.35M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.8M |
| 5 |
Primecap Management
Pasadena,
California
|
-$1.55M |
SPPI Hedge Fund Activity: Q3 2020 in Review
159 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2020, worth a combined $382M — up 53% from $250M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new SPPI positions and 22 closed out — a net gain of 1 holder — while 79 added to existing stakes and 26 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $28.8M. The largest seller was Morgan Stanley, cutting an estimated $4.03M.
- 159 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2020, up from 158 in Q2 2020.
- Funds reported $382M of Spectrum Pharmaceuticals Inc stock for Q3 2020, up 53% quarter-over-quarter.
- 23 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2020 and 22 closed out, a net change of +1 holder.
- The largest Spectrum Pharmaceuticals Inc buyer in Q3 2020 was Armistice Capital, an estimated $28.8M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q3 2020 was Morgan Stanley, an estimated $4.03M sold.
Based on aggregated 13F filings for Q3 2020.